AIW: DeCell to Pitch at BioPort
The pain that Paul Gratzer’s startup addresses is all too quantifiable and frightening: every 20 seconds, someone in the world loses a limb because of chronic foot ulcers caused by diabetes.
Gratzer is the founder and chief executive of DeCell Technologies Inc., which is commercializing a patented technology that could soon help to cure these ulcers quickly and affordably. The Halifax-based company has developed a natural scaffolding from human skin that can be placed over the ulcer to encourage the regeneration of skin cells and keep the wound clean to avoid infection. On Thursday,